Europe — EMA

Paclitaxel Accord Healthcare

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare, is a taxane presented as a strength/form for intravenous use. It treats various solid tumours and is used in adult oncology patients. GNH USA supplies Paclitaxel Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paclitaxel Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapeutic agent used in the treatment of several cancer types that affect the epithelial cells.

- Breast cancer: Improves the overall response rate and survival when combined with anthracycline‑based regimens. - Non‑small cell lung cancer: Enhances the efficacy of platinum‑based therapy in advanced disease. - Ovarian cancer: Used as maintenance therapy to prolong progression‑free survival. - Cervical cancer ( ) t t t t t \n-

What are the side effects of Paclitaxel?

This ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →